Drug Chatter -- Tracking biopharma stock chatter

Profile for Lifevantage Corporation (LXRX)

« Back to company index

LXRX Chatter Timeline

Stock Ticker for LXRX

Most Active Tweeters for LXRX

UserTweets
@traderal1 5
@ThisLincolnian 5
@dispatchtribune 4
@ZolmaxNews 3
@1MinuteStock 3

Recent Tweets for LXRX

InsiderAlertsIA @InsiderAlertsIA
$LXRX: New Insider Filing on EVP and CCO ALEXANDER A SANTINI: https://t.co/QaoIihrnnt
May 25th 2018, 4:05pm
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals $LXRX Earns “Outperform” Rating from Wedbush https://t.co/3MkjGEWaII
May 25th 2018, 12:05pm
tymorapro @tymorapro
$LXRX: At 1DyHIGH=9.70, hits:2, ch:+3.1%, 7phNewHi:BrkPLo[+3.5%], 17:3Accel+, tf:1011111, medFlt:43M, HiPctSht[30%:… https://t.co/E9IKgnphZJ
May 25th 2018, 11:05am
registrarjourn @registrarjourn
Lexicon Pharmaceuticals $LXRX Earns “Outperform” Rating from Wedbush https://t.co/0SmJ9izhlJ
May 25th 2018, 8:05am
lisagillis_ @lisagillis_
RT @ChartMill: $LXRX: The short term trend is positive, while the long term trend is neutral. So this is evolving in the right ... https://…
May 24th 2018, 7:05pm
ChartMill @ChartMill
$LXRX: The short term trend is positive, while the long term trend is neutral. So this is evolving in the right ...… https://t.co/gbKtE836pC
May 24th 2018, 7:05pm
ThisLincolnian @ThisLincolnian
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Earnings of -$0.35 Per Share https://t.co/VcZznzqigP
May 24th 2018, 3:05pm
ConsumerFeed @ConsumerFeed
Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Earnings of -$0.35 Per Share https://t.co/hTExU0L2fm
May 24th 2018, 3:05pm
MrCDanso @MrCDanso
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference $LXRX https://t.co/0ol6ZzF6Kt
May 24th 2018, 7:05am
GNWLive @GNWLive
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference $LXRX https://t.co/5PAMuNrMa8
May 24th 2018, 7:05am
SolarMelt @SolarMelt
$LXRX Rolling over. Negative MACD Crossover pending - should take a couple of days. Sentiment coming down fast brin… https://t.co/jTMB8fOTq1
May 24th 2018, 1:05am
fda_tracker @fda_tracker
$LXRX New PDUFA Date 2019-03-22 Lexicon Pharmaceuticals, Inc. Link:https://t.co/chfnrZCLdB Calendar:https://t.co/sCt1qKoMdr
May 23rd 2018, 9:05am
OlympiaReport @OlympiaReport
Lexicon Pharmaceuticals $LXRX Given Outperform Rating at Wedbush https://t.co/H8uopOJt5q
May 23rd 2018, 5:05am
dispatchtribune @dispatchtribune
Lexicon Pharmaceuticals $LXRX Given Outperform Rating at Wedbush https://t.co/CCvuTa0s3C
May 23rd 2018, 5:05am
traderal1 @traderal1
RT @Biotech_DD: $LXRX ??no cap raise overhang, cash sufficient to fund optations until cash flow positive ?? superior data set / v benign…
May 22nd 2018, 11:05pm
traderal1 @traderal1
RT @ThisLincolnian: Lexicon Pharmaceuticals’ $LXRX Outperform Rating Reaffirmed at Wedbush https://t.co/tBPeOn8Yan
May 22nd 2018, 11:05pm
traderal1 @traderal1
RT @StaticTrades: $LXRX FDA to review Zynquista (sotagliflozin) as potential treatment for type 1 diabetes
May 22nd 2018, 11:05pm
traderal1 @traderal1
RT @WatchlistN: Lexicon Pharmaceuticals’ $LXRX Outperform Rating Reaffirmed at Wedbush https://t.co/j6fCY1UI3H
May 22nd 2018, 11:05pm
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals’ $LXRX Outperform Rating Reaffirmed at Wedbush https://t.co/a68SyL55Gj #stocks
May 22nd 2018, 5:05pm
WatchlistN @WatchlistN
Lexicon Pharmaceuticals’ $LXRX Outperform Rating Reaffirmed at Wedbush https://t.co/j6fCY1UI3H
May 22nd 2018, 5:05pm
ThisLincolnian @ThisLincolnian
Lexicon Pharmaceuticals’ $LXRX Outperform Rating Reaffirmed at Wedbush https://t.co/tBPeOn8Yan
May 22nd 2018, 5:05pm
traderal1 @traderal1
RT @EEthougths: *LEXICON PHARMA RISES; GETS NEW STREET HIGH PT $42 AT WEDBUSH $LXRX
May 22nd 2018, 4:05pm
TheGoodKillers @TheGoodKillers
$LXRX wedbush, here's the brilliance of that shop https://t.co/6PSiQHI4fx
May 22nd 2018, 2:05pm
EEthougths @EEthougths
*LEXICON PHARMA RISES; GETS NEW STREET HIGH PT $42 AT WEDBUSH $LXRX
May 22nd 2018, 2:05pm
tymorapro @tymorapro
$LXRX: [10alerts] At 1DyHIGH=10.07, hits:2, ch:+2.2%, 0NewHi+:BrkPLo[+3.7%], 1mMv:+3, 3:1Accel+, tf:1000001, FirmTr… https://t.co/WOrz4xcZhI
May 22nd 2018, 2:05pm
StaticTrades @StaticTrades
$LXRX FDA to review Zynquista (sotagliflozin) as potential treatment for type 1 diabetes
May 22nd 2018, 8:05am
stefanomjr @stefanomjr
$LXRX Lexicon Pharma, Sanofi $SNY Announce FDA to Review Zynquista as Potential Treatment for Type 1 Diabetes https://t.co/vcNr5Q6GeU
May 22nd 2018, 8:05am
StockTexts @StockTexts
$LXRX $SNY FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes Nasdaq:LXRX https://t.co/OCLJVoi9QI
May 22nd 2018, 8:05am
stockelite @stockelite
$LXRX FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes https://t.co/ow3s0zOXIL
May 22nd 2018, 8:05am
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/J4XAJ7JDCr
May 21st 2018, 3:05am
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals $LXRX Raised to “Buy” at BidaskClub https://t.co/8TjpwxGo1w
May 20th 2018, 1:05pm
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals $LXRX Raised to “Buy” at BidaskClub https://t.co/FTX45g5NAT
May 20th 2018, 1:05pm
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals $LXRX Raised to “Buy” at BidaskClub https://t.co/jc1HoLRP2N
May 20th 2018, 1:05pm
dispatchtribune @dispatchtribune
Lexicon Pharmaceuticals $LXRX Rating Increased to Buy at BidaskClub https://t.co/wPOBPETBPH
May 20th 2018, 12:05pm
TranscriptDaily @TranscriptDaily
Lexicon Pharmaceuticals $LXRX Upgraded by BidaskClub to “Buy” https://t.co/7xryVzvgdP
May 19th 2018, 2:05pm
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals $LXRX Receives $25.25 Average Target Price from Analysts https://t.co/BJsJ4GdFpR
May 18th 2018, 8:05pm
ThisLincolnian @ThisLincolnian
Lexicon Pharmaceuticals $LXRX Given Consensus Recommendation of “Hold” by Brokerages https://t.co/Mu6FGeTRTr
May 18th 2018, 8:05pm
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals $LXRX Upgraded to Buy at BidaskClub https://t.co/9hUpMkvgrt
May 18th 2018, 2:05pm
registrarjourn @registrarjourn
Lexicon Pharmaceuticals $LXRX Upgraded to Buy at BidaskClub https://t.co/tigyVAkoPq
May 18th 2018, 2:05pm
dakotafinancial @dakotafinancial
Lexicon Pharmaceuticals $LXRX Lifted to “Buy” at BidaskClub https://t.co/rr6ODAVNkr
May 17th 2018, 2:05am
TheMarketsDaily @TheMarketsDaily
Lexicon Pharmaceuticals $LXRX Lifted to “Buy” at BidaskClub https://t.co/FDOdjwBauE
May 17th 2018, 2:05am
dakotafinancial @dakotafinancial
Brokerages Anticipate Lexicon Pharmaceuticals $LXRX Will Announce Quarterly Sales of $22.38 Million https://t.co/yDmMKDiBgB
May 16th 2018, 9:05pm
ledgerzette @ledgerzette
Lexicon Pharmaceuticals $LXRX – Research Analysts’ Weekly Ratings Changes https://t.co/q3sHpipuiI
May 16th 2018, 2:05pm
dakotafinancial @dakotafinancial
Lexicon Pharmaceuticals $LXRX – Research Analysts’ Weekly Ratings Changes https://t.co/au1JN0YpLg
May 16th 2018, 2:05pm
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals $LXRX – Research Analysts’ Weekly Ratings Changes https://t.co/JzQ6aJWKVS #stocks
May 16th 2018, 2:05pm
TheMarketsDaily @TheMarketsDaily
Lexicon Pharmaceuticals $LXRX – Research Analysts’ Weekly Ratings Changes https://t.co/c3wwiHXUeZ
May 16th 2018, 2:05pm
dispatchtribune @dispatchtribune
Brokerages Set Lexicon Pharmaceuticals $LXRX Target Price at $25.25 https://t.co/M8fQAjV1lu
May 16th 2018, 11:05am
WeekHerald @WeekHerald
Lexicon Pharmaceuticals $LXRX Receives $25.25 Consensus Price Target from Analysts https://t.co/0J0KoQZVrl
May 16th 2018, 11:05am
ZolmaxNews @ZolmaxNews
Brokerages Anticipate Lexicon Pharmaceuticals $LXRX Will Announce Earnings of -$0.42 Per Share https://t.co/v8mi1FJWnX
May 14th 2018, 8:05pm
WatchlistN @WatchlistN
Zacks: Brokerages Expect Lexicon Pharmaceuticals $LXRX to Announce -$0.42 Earnings Per Share https://t.co/jN0NNlRGO0
May 14th 2018, 8:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.